Fresenius Medical Care AG (FMS) Receivables - Other (2009 - 2025)

Fresenius Medical Care AG (FMS) has 17 years of Receivables - Other data on file, last reported at $144.7 million in Q4 2025.

• In Q4 2025, Receivables - Other rose 24.3% year-over-year to $144.7 million; the TTM figure through Dec 2025 stood at $144.7 million (up 24.3% YoY), while the FY2025 annual figure was $144.7 million, up 24.3% from the prior year.
• Receivables - Other improved to $144.7 million in Q4 2025, from $38.6 million in the prior quarter.
• Across five years, Receivables - Other topped out at $250.5 million in Q4 2023 and bottomed at -$34.7 million in Q3 2021.
• A 5-year average of $76.9 million and a median of $55.0 million in 2023 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2022 — Receivables - Other sank 314.08% — and 2023, when it jumped 368.26%.
• Year by year, Receivables - Other stood at $130.2 million in 2021, then soared by 55.55% to $202.6 million in 2022, then climbed by 23.68% to $250.5 million in 2023, then plunged by 53.54% to $116.4 million in 2024, then rose by 24.3% to $144.7 million in 2025.
• The last three Receivables - Other figures came in at $144.7 million (Q4 2025), $38.6 million (Q3 2025), and $40.5 million (Q2 2025), per Business Quant data.

Peer Comparison